Monoclonal B-cell lymphocytosis (MBL): biology, natural history and clinical management.
paper
Cited
Public
- Authors
- Shanafelt, T D; Ghia, P; Lanasa, M C; Landgren, O; Rawstron, A C
- Year
- 2010
- Journal
- Leukemia
- PMID
- 20090778
- DOI
- 10.1038/leu.2009.287
- PMCID
- PMC3913172
Chronic lymphocytic leukemia (CLL) and the other low-grade non-Hodgkin lymphomas are among the most common lymphoid malignancies. Recent studies suggest that more than 4% of the general population over age 40 harbor a population of clonal B cells with the phenotype of either CLL or another B-cell malignancy, a condition now designated monoclonal B-cell lymphocytosis (MBL). Although all cases of CLL appear to be preceded by MBL, the majority of individuals with MBL will not develop a hematologic malignancy. The biologic characteristics and clinical implications of MBL appear to differ based on whether it is identified during the diagnostic evaluation of lymphocytosis or incidentally discovered through screening of individuals with normal lymphocyte counts as part of research studies using highly sensitive detection methods. In this paper, we provide a state of the art review on the prevalence, nomenclature, biology, natural history and clinical management of MBL.
No figures extracted from this document.
1β20 of 49
Next β
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| Detectable clonal mosaicism from birth to old age and its relationship to cancer. | 2012 | 22561516 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Lymphocyte count and risk of chronic lymphocytic leukemia. | Pahnke S et al. | β | 2026 | β |
| Multiple myeloma with concomitant chronic lymphocytic leukemia: evidence for independent clonal origin. | Wobst J et al. | β | 2026 | β |
| Machine Learning Model Predicts Abnormal Lymphocytosis Associated With Chronic Lymphocytic Leukemia. | Aoki J et al. | β | 2025 | β |
| Progressive T cell defects correlate with disease outcome in high-count monoclonal B-cell lymphocytosis. | Parikh SA et al. | β | 2025 | β |
| Stereotyped B-Cell Receptor Immunoglobulins in B-Cell Lymphomas. | Agathangelidis A et al. | β | 2025 | β |
| The role of imaging studies in predicting time to first treatment and overall survival in high-count monoclonal B-cell lymphocytosis. | Kosydar S et al. | β | 2025 | β |
| CD20+ T cells in monoclonal B cell lymphocytosis and chronic lymphocytic leukemia: frequency, phenotype and association with disease progression. | Rodrigues C et al. | β | 2024 | β |
| Defining precancer: a grand challenge for the cancer community. | Faupel-Badger J et al. | β | 2024 | β |
| Evidence-Based Management of Chronic Lymphocytic Leukemia: Consensus Statements from the Gulf Region. | Alshemmari SH et al. | β | 2024 | β |
| Genetic alterations in chronic lymphocytic leukemia and plasma cell neoplasmsΒ - a practical guide to WHO HAEM5. | Tausch E et al. | β | 2024 | β |
| The dark side of stemness - the role of hematopoietic stem cells in development of blood malignancies. | Filipek-GorzaΕa J et al. | β | 2024 | β |
| Tumor mutational load is prognostic for progression to therapy among high-count monoclonal B-cell lymphocytosis. | Kleinstern G et al. | β | 2024 | β |
| Genetic drivers in the natural history of chronic lymphocytic leukemia development as early as 16 years before diagnosis. | Kolijn PM et al. | β | 2023 | β |
| Rare Case of Concomitant Polycythemia Vera and Chronic Lymphocytic Leukemia in a Young Male Patient. | Li T et al. | β | 2023 | β |
| The inherited genetic contribution and polygenic risk score for risk of CLL and MBL: a narrative review. | Kleinstern G et al. | β | 2023 | β |
| Humoral and cellular immune responses to recombinant herpes zoster vaccine in patients with chronic lymphocytic leukemia and monoclonal B cell lymphocytosis. | Muchtar E et al. | β | 2022 | β |
| Minimal/Measurable Disease Analysis in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma by Flow Cytometry. | Gao Q et al. | β | 2022 | β |
| Monoclonal B-cell lymphocytosis in the bone marrow: revisiting the criteria for chronic lymphocytic leukemia/small lymphocytic lymphoma. | Ryder CB et al. | β | 2022 | β |
| Progression and survival of MBL: a screening study of 10β139 individuals. | Slager SL et al. | β | 2022 | β |
| 14-Color single tube for flow cytometric characterization of CD5+ B-LPDs and high sensitivity automated minimal residual disease quantitation of CLL/SLL. | Goshaw JM et al. | β | 2021 | β |
| Aberrant expression of CD54 detected by flow cytometry is a characteristic of B-lymphoma cells in bone marrow specimens. | Wang W et al. | β | 2021 | β |
| Application of CD54 in diagnosing bone marrow involvement by using flow cytometry in patients with diffuse large B-cell lymphoma. | Wang W et al. | β | 2021 | β |
| Chronic Lymphocytic Leukemia. | Chiorazzi N et al. | β | 2021 | β |
| Health impact of monoclonal gammopathy of undetermined significance (MGUS) and monoclonal B-cell lymphocytosis (MBL): findings from a UK population-based cohort. | Lamb MJ et al. | β | 2021 | β |
| Hematological and Genetic Markers in the Rational Approach to Patients With HCV Sustained Virological Response With or Without Persisting Cryoglobulinemic Vasculitis. | Gragnani L et al. | β | 2021 | β |
| Monoclonal B-cell Lymphocytosis Exacerbated by Prednisolone Therapy for Dermatomyositis. | Kume A et al. | β | 2021 | β |
| Monoclonal B lymphocytosis in a kidney transplant recipient. | Plessi J et al. | β | 2021 | β |
| Natural history of monoclonal B-cell lymphocytosis among relatives in CLL families. | Slager SL et al. | β | 2021 | β |
| Risk of serious infection among individuals with and without low count monoclonal B-cell lymphocytosis (MBL). | Shanafelt TD et al. | β | 2021 | β |
| The CLL International Prognostic Index predicts outcomes in monoclonal B-cell lymphocytosis and Rai 0 CLL. | Parikh SA et al. | β | 2021 | β |
| The humoral immune response to high-dose influenza vaccine in persons with monoclonal B-cell lymphocytosis (MBL) and chronic lymphocytic leukemia (CLL). | Whitaker JA et al. | β | 2021 | β |
| Understanding Monoclonal B Cell Lymphocytosis: An Interplay of Genetic and Microenvironmental Factors. | Galigalidou C et al. | β | 2021 | β |
| A higher frequency of monoclonal B cell lymphocytosis among Egyptian relatives of CLL patients. | Kassem S et al. | β | 2020 | β |
| A novel transgenic mouse strain expressing PKCΞ²II demonstrates expansion of B1 and marginal zone B cell populations. | Azar AA et al. | β | 2020 | β |
| Chronic lymphocytic leukemia in 2020: a surfeit of riches? | Parikh SA et al. | β | 2020 | β |
| Health impact of monoclonal gammopathy of undetermined significance (MGUS) and monoclonal B-cell lymphocytosis (MBL): findings from a UK population-based cohort | Lamb M et al. | β | 2020 | β |
| Leptomeningeal metastasis in a marginal zone lymphoma, presenting as a delirium: case report. | Dreessen L et al. | β | 2020 | β |
| Screening for monoclonal B-lymphocyte expansion in a hospital-based Chinese population with lymphocytosis: an observational cohort study. | Xu J et al. | β | 2020 | β |
| Tumor mutational load predicts time to first treatment in chronic lymphocytic leukemia (CLL) and monoclonal B-cell lymphocytosis beyond the CLL international prognostic index. | Kleinstern G et al. | β | 2020 | β |
| A significant proportion of patients with primary central nervous system lymphoma harbor clonal bone marrow B-cells. | Brandt A et al. | β | 2019 | β |
| Chronic lymphocytic leukaemia: from genetics to treatment. | Bosch F et al. | β | 2019 | β |
| Diagnosis and classification of lymphoma: Impact of technical advances. | Jaffe ES | β | 2019 | β |
| Dreams can come true: the first steps toward a peripheral blood screening test for the early detection of tumors have been taken. | Haferlach C et al. | β | 2019 | β |
| Early Events in Lymphoid Neoplasms and Indolent Follicular Lymphomas. | Perincheri S | β | 2019 | β |
| The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group. | Leung N et al. | β | 2019 | β |
| Immunophenotypic profile and clinical outcome of monoclonal B-cell lymphocytosis in kidney transplantation. | Alfano G et al. | β | 2018 | β |
| Low-count monoclonal B-cell lymphocytosis persists after seven years of follow up and is associated with a poorer outcome. | Criado I et al. | β | 2018 | β |
| Lymphoma-like monoclonal B cell lymphocytosis in a patient population: biology, natural evolution, and differences from CLL-like clones. | Vander Meeren S et al. | β | 2018 | β |
| Monoclonal B-cell lymphocytosis: Does the elderly patient need a specialistic approach? | Angelillo P et al. | β | 2018 | β |
| Outcomes of a large cohort of individuals with clinically ascertained high-count monoclonal B-cell lymphocytosis. | Parikh SA et al. | β | 2018 | β |
| Residual normal B-cell profiles in monoclonal B-cell lymphocytosis versus chronic lymphocytic leukemia. | Criado I et al. | β | 2018 | β |
| Chronic lymphocytic leukaemia. | Kipps TJ et al. | β | 2017 | β |
| Clonal B-cell lymphocytosis of marginal zone origin. | Xochelli A et al. | β | 2017 | β |
| Clonal hematopoiesis. | Jan M et al. | β | 2017 | β |
| Detection of L265P MYD-88 mutation in a series of clonal B-cell lymphocytosis of marginal zone origin (CBL-MZ). | Kalpadakis C et al. | β | 2017 | β |
| Early stages in the ontogeny of small B-cell lymphomas: genetics and microenvironment. | Ghia P et al. | β | 2017 | β |
| Genomic characterization of high-count MBL cases indicates that early detection of driver mutations and subclonal expansion are predictors of adverse clinical outcome. | Barrio S et al. | β | 2017 | β |
| Host virus and pneumococcus-specific immune responses in high-count monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia: implications for disease progression. | Criado I et al. | β | 2017 | β |
| Monoclonal B-cell lymphocytosis in a hospital-based UK population and a rural Ugandan population: a cross-sectional study. | Rawstron AC et al. | β | 2017 | β |
| Monoclonal Gammopathy of Undetermined Significance After Kidney Transplantation: Single-Center Experience. | Alfano G et al. | β | 2017 | β |
| A Patient with Abnormal Kidney Function and a Monoclonal Light Chain in the Urine. | Leung N et al. | β | 2016 | β |
| Chronic lymphocytic leukaemia. | ScarfΓ² L et al. | β | 2016 | β |
| Detection of non-CLL-like monoclonal B cell lymphocytosis increases dramatically in the very elderly, while detection of CLL-like populations varies by race: findings in a multiethnic population-based cohort of elderly women. | Edlefsen KL et al. | β | 2016 | β |
| Frequency of monoclonal B-cell lymphocytosis in relatives of patients with chronic lymphocytic leukemia. | Villegas Gracia R et al. | β | 2016 | β |
| Monoclonal B-cell lymphocytosis in the population of Slovenian region of Lower Carniola. | Bajuk P et al. | β | 2016 | β |
| Next-generation IgVH sequencing CLL-like monoclonal B-cell lymphocytosis reveals frequent oligoclonality and ongoing hypermutation. | Klinger M et al. | β | 2016 | β |
| Paraprotein-Related Kidney Disease: Diagnosing and Treating Monoclonal Gammopathy of Renal Significance. | Rosner MH et al. | β | 2016 | β |
| Prognostic indices in chronic lymphocytic leukaemia: where do we stand how do we proceed? | Baliakas P et al. | β | 2016 | β |
| Risk of non-hematologic cancer in individuals with high-count monoclonal B-cell lymphocytosis. | Solomon BM et al. | β | 2016 | β |
| A seven-gene expression panel distinguishing clonal expansions of pre-leukemic and chronic lymphocytic leukemia B cells from normal B lymphocytes. | McCarthy BA et al. | β | 2015 | β |
| Clinicopathological and phenotypic features of chronic NK cell lymphocytosis identified among patients with asymptomatic lymphocytosis. | Cao F et al. | β | 2015 | β |
| Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes. | Steensma DP et al. | β | 2015 | β |
| Deciphering the molecular landscape in chronic lymphocytic leukemia: time frame of disease evolution. | Sutton LA et al. | β | 2015 | β |
| Hospital population screening reveals overrepresentation of CD5(-) monoclonal B-cell lymphocytosis and monoclonal gammopathy of undetermined significance of IgM type. | Voigtlaender M et al. | β | 2015 | β |
| Immunophenotypic analysis reveals heterogeneity and common biologic aspects in monoclonal B-cell lymphocytosis. | Kostopoulos IV et al. | β | 2015 | β |
| Lag times between lymphoproliferative disorder and clinical diagnosis of chronic lymphocytic leukemia: a prospective analysis using plasma soluble CD23. | Kaaks R et al. | β | 2015 | β |
| Monoclonal B-cell lymphocytosis. | Biasoli I et al. | β | 2015 | β |
| Monoclonal B-cell lymphocytosis and early-stage chronic lymphocytic leukemia: diagnosis, natural history, and risk stratification. | Strati P et al. | β | 2015 | β |
| Nodal monoclonal CD5-positive B-lymphocytosis and toxoplasma lymphadenitis: another variant in the spectrum of infectious lymphadenitis in patients with chronic leukemia/small lymphocytic lymphoma. | Pagni F et al. | β | 2015 | β |
| Preventing clonal evolutionary processes in cancer: Insights from mathematical models. | Rodriguez-Brenes IA et al. | β | 2015 | β |
| Two cases of concurrent development of essential thrombocythemia with chronic lymphocytic leukemia, one related to clonal B-cell lymphocytosis, tested by array comparative genomic hybridization. | Kim H et al. | β | 2015 | β |
| Acquired chromosomal anomalies in chronic lymphocytic leukemia patients compared with more than 50,000 quasi-normal participants. | Laurie CC et al. | β | 2014 | β |
| Changes in the incidence, pattern of presentation and clinical outcome of early chronic lymphocytic leukemia patients using the 2008 International Workshop on CLL guidelines. | Molica S et al. | β | 2014 | β |
| Clonal B-cell lymphocytosis exhibiting immunophenotypic features consistent with a marginal-zone origin: is this a distinct entity? | Xochelli A et al. | β | 2014 | β |
| Early lymphoid lesions: conceptual, diagnostic and clinical challenges. | Ganapathi KA et al. | β | 2014 | β |
| High-throughput sequencing for the identification of NOTCH1 mutations in early stage chronic lymphocytic leukaemia: biological and clinical implications. | Lionetti M et al. | β | 2014 | β |
| Incidence of chronic lymphocytic leukemia and high-count monoclonal B-cell lymphocytosis using the 2008 guidelines. | Call TG et al. | β | 2014 | β |
| Management of chronic lymphocytic leukemia. | Ghia P et al. | β | 2014 | β |
| Monoclonal B-cell lymphocytosis. | D'Arena G et al. | β | 2014 | β |
| Monoclonal B cell lymphocytosis and "in situ" lymphoma. | Karube K et al. | β | 2014 | β |
| Monoclonal B-cell lymphocytosis is characterized by mutations in CLL putative driver genes and clonal heterogeneity many years before disease progression. | Ojha J et al. | β | 2014 | β |
| Multidimensional scaling analysis identifies pathological and prognostically relevant profiles of circulating T-cells in chronic lymphocytic leukemia. | Rissiek A et al. | β | 2014 | β |
| New insights into monoclonal B-cell lymphocytosis. | Kalpadakis C et al. | β | 2014 | β |
| Occult monoclonal B-cell disorder of hyoid bone. | Pagni F et al. | β | 2014 | β |
| t(14;18) Translocation: A predictive blood biomarker for follicular lymphoma. | Roulland S et al. | β | 2014 | β |
| Analysis of SF3B1 mutations in monoclonal B-cell lymphocytosis. | Greco M et al. | β | 2013 | β |
| Chronic lymphocytic leukemia: molecular heterogeneity revealed by high-throughput genomics. | Landau DA et al. | β | 2013 | β |
| Clinical implications of the molecular genetics of chronic lymphocytic leukemia. | FoΓ R et al. | β | 2013 | β |
| Clinical monoclonal B lymphocytosis versus Rai 0 chronic lymphocytic leukemia: A comparison of cellular, cytogenetic, molecular, and clinical features. | Morabito F et al. | β | 2013 | β |
| Combined patterns of IGHV repertoire and cytogenetic/molecular alterations in monoclonal B lymphocytosis versus chronic lymphocytic leukemia. | Henriques A et al. | β | 2013 | β |
| Early neoplastic lymphoid lesions. | Carvajal-Cuenca A et al. | β | 2013 | β |
| Immunogenetics shows that not all MBL are equal: the larger the clone, the more similar to CLL. | Vardi A et al. | β | 2013 | β |
| Infectious complications among individuals with clinical monoclonal B-cell lymphocytosis (MBL): a cohort study of newly diagnosed cases compared to controls. | Moreira J et al. | β | 2013 | β |
| [In situ lymphoma and other early stage malignant non-Hodgkin lymphomas]. | Quintanilla-MartΓnez L et al. | β | 2013 | β |
| Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia. | Rossi D et al. | β | 2013 | β |
| [Leg ulcer associated with type I cryoglobulinaemia due to incipient B-cell lymphoma]. | Lacoste C et al. | β | 2013 | β |
| MBL versus CLL: how important is the distinction? | ScarfΓ² L et al. | β | 2013 | β |
| Monoclonal B cell lymphocytosis--what does it really mean? | Rawstron AC | β | 2013 | β |
| [Monoclonal gammopathy of undetermined significance and monoclonal B-lymphocytosis]. | HΓΌbel K et al. | β | 2013 | β |
| Nodal and leukemic small B-cell neoplasms. | Cook JR | β | 2013 | β |
| Prognostic value of miR-155 in individuals with monoclonal B-cell lymphocytosis and patients with B chronic lymphocytic leukemia. | Ferrajoli A et al. | β | 2013 | β |
| Single-agent Smac-mimetic compounds induce apoptosis in B chronic lymphocytic leukaemia (B-CLL). | Scavullo C et al. | β | 2013 | β |
| Spontaneous regression of chronic lymphocytic leukemia to a monoclonal B-lymphocytosis or to a normal phenotype. | Nakhla PS et al. | β | 2013 | β |
| T-cell clonality is detected in a high frequency among patients with incidental lymphocytosis by PCR assays for TCR gene rearrangements. | Cao F et al. | β | 2013 | β |
| The role of bone marrow biopsy examination at diagnosis of chronic lymphocytic leukemia: a reappraisal. | Baliakas P et al. | β | 2013 | β |
| Analysis of NOTCH1 mutations in monoclonal B-cell lymphocytosis. | Rasi S et al. | β | 2012 | β |
| An increased number of individuals with clinically recognized monoclonal B-cell lymphocytosis characterizes a recent database of chronic lymphocytic leukemia Rai stage 0. | Molica S et al. | β | 2012 | β |
| Case study interpretation--Portland: Case 1. Hairy cell leukemia with CLL-like monoclonal B lymphocytosis. | Tembhare P et al. | β | 2012 | β |
| Chronic lymphocytic leukemia specific T-cell subset alterations are clone-size dependent and not present in monoclonal B lymphocytosis. | te Raa GD et al. | β | 2012 | β |
| Clinical aspects of monoclonal B-cell lymphocytosis. | Mowery YM et al. | β | 2012 | β |
| Concurrent epigenetic silencing of wnt/Ξ²-catenin pathway inhibitor genes in B cell chronic lymphocytic leukaemia. | Moskalev EA et al. | β | 2012 | β |
| Detectable clonal mosaicism from birth to old age and its relationship to cancer. | Laurie CC et al. | β | 2012 | β |
| Early lesions in lymphoid neoplasia: Conclusions based on the Workshop of the XV. Meeting of the European Association of Hematopathology and the Society of Hematopathology, in Uppsala, Sweden. | Fend F et al. | β | 2012 | β |
| Impact of B-cell count and imaging screening in cMBL: any need to revise the current guidelines? | ScarfΓ² L et al. | β | 2012 | β |
| [Leukemia- and lymphoma-associated flow cytometric, cytogenetic, and molecular genetic aberrations in healthy individuals]. | JakΓ³ J et al. | β | 2012 | β |
| Monoclonal B-cell lymphocytosis: a reappraisal of its clinical implications. | Molica S et al. | β | 2012 | β |
| Monoclonal B-cell lymphocytosis is closely related to chronic lymphocytic leukaemia and may be better classified as early-stage CLL. | Kern W et al. | β | 2012 | β |
| Monoclonal B-cell lymphocytosis (MBL, CD4+/CD8 weak T-cell large granular lymphocytic leukemia (T-LGL leukemia) and monoclonal gammopathy of unknown significance (MGUS): molecular and flow cytometry characterization of three concomitant hematological disorders. | Matos DM et al. | β | 2012 | β |
| Monoclonal B-cell lymphocytosis (MBL) with normal lymphocyte counts is associated with decreased numbers of normal circulating B-cell subsets. | Hauswirth AW et al. | β | 2012 | β |
| Monoclonal B-cell lymphocytosis: right track or red herring? | Ghia P et al. | β | 2012 | β |
| Monoclonal B-lymphocytosis: reflections and definitions. | Mulligan SP | β | 2012 | β |
| The current lymphoma classification: new concepts and practical applications triumphs and woes. | Bakshi N et al. | β | 2012 | β |
| The diverse roles of IRF4 in late germinal center B-cell differentiation. | De Silva NS et al. | β | 2012 | β |
| A Case of Monoclonal Lymphoplasmacytosis of the Bone Marrow with IgM-Positive Russell Bodies. | Kayano H et al. | β | 2011 | β |
| Another piece of the puzzle: is there a "nodal" monoclonal B-cell lymphocytosis? | Ghia P | β | 2011 | β |
| Circulating regulatory T cells in "clinical" monoclonal B-cell lymphocytosis. | D'Arena G et al. | β | 2011 | β |
| CLL-like B-lymphocytes are systematically present at very low numbers in peripheral blood of healthy adults. | Almeida J et al. | β | 2011 | β |
| Differentiating chronic lymphocytic leukemia from monoclonal B-lymphocytosis according to clinical outcome: on behalf of the GIMEMA chronic lymphoproliferative diseases working group. | Molica S et al. | β | 2011 | β |
| General population low-count CLL-like MBL persists over time without clinical progression, although carrying the same cytogenetic abnormalities of CLL. | Fazi C et al. | β | 2011 | β |
| Immunologic aspects of monoclonal B-cell lymphocytosis. | Lanasa MC et al. | β | 2011 | β |
| Immunophenotypic and gene expression analysis of monoclonal B-cell lymphocytosis shows biologic characteristics associated with good prognosis CLL. | Lanasa MC et al. | β | 2011 | β |
| Infectious mononucleosis and monoclonal B lymphocytosis in an elderly man. | Malfuson JV et al. | β | 2011 | β |
| Molecular characterization of a t(2;7) translocation linking CDK6 to the IGK locus in CD5(-) monoclonal B-cell lymphocytosis. | Parker E et al. | β | 2011 | β |
| Monoclonal B-cell lymphocytosis: a brief review for general clinicians. | Matos DM et al. | β | 2011 | β |
| Monoclonal B-lymphocytosis: demographics, nature and subclassification in 414 community patients. | Mulligan CS et al. | β | 2011 | β |
| Reassessment of small lymphocytic lymphoma in the era of monoclonal B-cell lymphocytosis. | Gibson SE et al. | β | 2011 | β |
| Recent advances in cytometry applications: preclinical, clinical, and cell biology. | Mittag A et al. | β | 2011 | β |
| Regulatory T cells predict the time to initial treatment in early stage chronic lymphocytic leukemia. | Weiss L et al. | β | 2011 | β |
| The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications. | Campo E et al. | β | 2011 | β |
| VΞ³9VΞ΄2 T cell-based immunotherapy in hematological malignancies: from bench to bedside. | Castella B et al. | β | 2011 | β |
| A computer simulation for exploring the detection of monoclonal B-cell lymphocytosis by flow cytometry. | Champion PD | β | 2010 | β |
| CLL-like monoclonal B-cell lymphocytosis: are we all bound to have it? | ScarfΓ² L et al. | β | 2010 | β |
| Common occurrence of monoclonal B-cell lymphocytosis among members of high-risk CLL families. | Goldin LR et al. | β | 2010 | β |
| LEF-1 is a prosurvival factor in chronic lymphocytic leukemia and is expressed in the preleukemic state of monoclonal B-cell lymphocytosis. | Gutierrez A et al. | β | 2010 | β |
| Monoclonal B cell lymphocytosis: clinical and population perspectives. | Caporaso NE et al. | β | 2010 | β |
| Non-CLL-like monoclonal B-cell lymphocytosis in the general population: prevalence and phenotypic/genetic characteristics. | Nieto WG et al. | β | 2010 | β |
| Transmission of leukemic donor cells by allogeneic stem cell transplantation in a context of familial CLL: should we screen donors for MBL? | Flandrin-Gresta P et al. | β | 2010 | β |